Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357)

Currency in CNY
25.12
+0.35(+1.41%)
Closed·
300357 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
24.6625.50
52 wk Range
16.3229.21
Key Statistics
Bid/Ask
25.12 / 25.12
Prev. Close
24.77
Open
24.66
Day's Range
24.66-25.5
52 wk Range
16.32-29.21
Volume
15.38M
Average Volume (3m)
7.69M
1-Year Change
32.62%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300357 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.58
Downside
-6.13%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Company Profile

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kit; and Changdian II, a house dust mite skin prick diagnosis kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.

Employees
1679
Market
China

Compare 300357 to Peers and Sector

Metrics to compare
300357
Peers
Sector
Relationship
P/E Ratio
41.7x32.3x−0.5x
PEG Ratio
−66.50−1.040.00
Price/Book
5.4x3.0x2.6x
Price / LTM Sales
14.0x4.4x3.2x
Upside (Analyst Target)
−6.1%12.2%41.9%
Fair Value Upside
Unlock4.4%4.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 23.58
(-6.13% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.60%
Dividend Yield
0.89%
Industry Median 1.53%
Annualised payout
0.22
Paid annually
5-Years Growth
+4.10%
Growth Streak

Earnings

Latest Release
Apr 18, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
228.47M / --
EPS Revisions
Last 90 days

300357 Income Statement

FAQ

What Stock Exchange Does Zhejiang Wolwo Bio-Pharma Trade On?

Zhejiang Wolwo Bio-Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Wolwo Bio-Pharma?

The stock symbol for Zhejiang Wolwo Bio-Pharma is "300357."

What Is the Zhejiang Wolwo Bio-Pharma Market Cap?

As of today, Zhejiang Wolwo Bio-Pharma market cap is 13.14B.

What Is Zhejiang Wolwo Bio-Pharma's Earnings Per Share (TTM)?

The Zhejiang Wolwo Bio-Pharma EPS (TTM) is 0.60.

When Is the Next Zhejiang Wolwo Bio-Pharma Earnings Date?

Zhejiang Wolwo Bio-Pharma will release its next earnings report on 21 Oct 2025.

From a Technical Analysis Perspective, Is 300357 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang Wolwo Bio-Pharma Stock Split?

Zhejiang Wolwo Bio-Pharma has split 3 times.

How Many Employees Does Zhejiang Wolwo Bio-Pharma Have?

Zhejiang Wolwo Bio-Pharma has 1679 employees.

What is the current trading status of Zhejiang Wolwo Bio-Pharma (300357)?

As of 24 Jul 2025, Zhejiang Wolwo Bio-Pharma (300357) is trading at a price of 25.12, with a previous close of 24.77. The stock has fluctuated within a day range of 24.66 to 25.50, while its 52-week range spans from 16.32 to 29.21.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.